Location History:
- Palo Alto, CA (US) (2014)
- Basel, CH (2014)
Company Filing History:
Years Active: 2014
Title: Eileen E Jackson-Ugueto: Innovator in Pharmaceutical Chemistry
Introduction
Eileen E Jackson-Ugueto is a prominent inventor based in Palo Alto, CA, known for her significant contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, she has made strides in the treatment of hyperproliferative diseases, including various forms of cancer. Her work has led to the filing of two patents that showcase her expertise and dedication to advancing medical science.
Latest Patents
Eileen's latest patents include "Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture." This invention is directed to compounds of Formula I and their pharmaceutically acceptable salts or solvates. The compounds are designed to inhibit, regulate, and modulate PI3K and/or mTOR, which are crucial in the pathology of several cancers. The invention provides methods for making and using these compounds in the treatment of diseases such as breast cancer, renal cell carcinoma, and melanoma, among others.
Career Highlights
Eileen is currently associated with Exelixis, Inc., where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in developing therapies that target critical pathways involved in cancer progression. With a total of 2 patents to her name, she has established herself as a key figure in her field.
Collaborations
Throughout her career, Eileen has collaborated with notable colleagues, including Joerg Bussenius and Larisa Dubenko. These partnerships have enhanced her research efforts and contributed to the successful development of her patented inventions.
Conclusion
Eileen E Jackson-Ugueto's innovative work in pharmaceutical chemistry exemplifies her commitment to improving cancer treatment through targeted therapies. Her patents reflect her expertise and the potential impact of her research on the medical field.